These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38696451)

  • 21. Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.
    Zhao G; Zhu M; Li Y; Zhang G; Li Y
    Expert Opin Drug Discov; 2024 Jun; 19(6):725-740. PubMed ID: 38753553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragment-based drug discovery and molecular docking in drug design.
    Wang T; Wu MB; Chen ZJ; Chen H; Lin JP; Yang LR
    Curr Pharm Biotechnol; 2015; 16(1):11-25. PubMed ID: 25420726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolutionary Multiobjective Molecule Optimization in an Implicit Chemical Space.
    Xia X; Liu Y; Zheng C; Zhang X; Wu Q; Gao X; Zeng X; Su Y
    J Chem Inf Model; 2024 Jul; 64(13):5161-5174. PubMed ID: 38870455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
    Huang B; Kang D; Zhan P; Liu X
    Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stalis: A Computational Method for Template-Based Ab Initio Ligand Design.
    Lee HS; Im W
    J Comput Chem; 2019 Jun; 40(17):1622-1632. PubMed ID: 30829435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.
    Muchiri RN; Kibitel J; Redick MA; van Breemen RB
    J Am Soc Mass Spectrom; 2022 Jan; 33(1):181-188. PubMed ID: 34939787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational approaches streamlining drug discovery.
    Sadybekov AV; Katritch V
    Nature; 2023 Apr; 616(7958):673-685. PubMed ID: 37100941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fragment-based drug discovery: concept and aim].
    Tanaka D
    Yakugaku Zasshi; 2010 Mar; 130(3):315-23. PubMed ID: 20190516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of Solution NMR in Drug Discovery.
    Shi L; Zhang N
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33499337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OptiMol: Optimization of Binding Affinities in Chemical Space for Drug Discovery.
    Boitreaud J; Mallet V; Oliver C; Waldispühl J
    J Chem Inf Model; 2020 Dec; 60(12):5658-5666. PubMed ID: 32986426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.
    Hu J; Liu Z; Yu DJ; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2209-2218. PubMed ID: 29462237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.
    Cournia Z; Allen B; Sherman W
    J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solving the Competitive Binding Equilibria between Many Ligands: Application to High-Throughput Screening and Affinity Optimization.
    Blay V; Otero-Muras I; Annis DA
    Anal Chem; 2020 Sep; 92(18):12630-12638. PubMed ID: 32812419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragment-based drug design: computational & experimental state of the art.
    Hoffer L; Renaud JP; Horvath D
    Comb Chem High Throughput Screen; 2011 Jul; 14(6):500-20. PubMed ID: 21521152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking.
    Karki N; Verma N; Trozzi F; Tao P; Kraka E; Zoltowski B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico fragment-based drug design.
    Konteatis ZD
    Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.